NHS England pauses new referrals for masculinising or feminising hormone treatment in under-18s

Review finds evidence does not back use of treatment for 16 and 17-year-olds with gender incongruence or dysphoria

The NHS is pausing new referrals for masculinising or feminising hormone treatment for 16 and 17-year-olds after an in-depth review found there was insufficient evidence to support its continued use.

Prescriptions for hormones had been available in England for under-18s with a diagnosis of gender incongruence or dysphoria who met certain criteria.